Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 2Polfa Tarchomin
03 2Adcock Ingram
04 1Alter Laboratories Sa
05 1Aristo Pharma GmbH
06 1BASI
07 2Bharat Parenterals Limited
08 2BioMatrix Healthcare
09 1Cifarma
10 1Cinfa
11 2DANHSON
12 2Flagship Biotech International Pvt. Ltd
13 6GL Pharma
14 1Harson Laboratories
15 2KIVIPharm
16 1Kalcex
17 1Kwality Pharmaceuticals
18 2LABORATORIOS NORMON SA
19 2Laboratorio Valma
20 1Laboratorios ERN
21 2Mars Therapeutics
22 1Maxheal Pharmaceuticals (India) Ltd
23 1Mepha Pharma
24 1Mepro Pharmaceuticals
25 2Montage Laboratories
26 1MosFarma
27 1Neogen N.V.
28 4Opel Healthcare Switzerland Ag
29 4Opella Healthcare Group
30 2Pannon
31 1Polifarma
32 1Reyoung pharmaceutical
33 1SINTETICA SA
34 2Spirig Healthcare
35 4Streuli Pharma
36 1Umedica Laboratories
37 1Vecol
38 2Zentiva
39 1Zuma Pharma
01 1Capsule
02 1Coated Tablet
03 2DC Granules
04 1Film Coated Tablet
05 1Hard Capsule
06 1INJ
07 1INJECTION
08 7Injectable Solution
09 10Injection
10 1Injection Solution
11 2Liquid Injection
12 1Oral Drop
13 2Oral Drop In Solution
14 2Oral Drops
15 3Oral Solution
16 1Solution For Injection
17 3Solution for Injection
18 1Sterile Solution
19 1Suppository
20 4TAB
21 1TABLET
22 20Tablet
23 3Blank
01 12Allowed
02 8Authorized
03 2Cancelled
04 5Dossier Availability- Q2 2017
05 1Dossier Availability- Q4 2016
06 2Dossier Availability: Q3 2024
07 6Generic
08 3Originator
09 31Blank
01 1Analgin
02 1Buscapina Compositum
03 2Buscopan compositum 10 mg/250 mg
04 1Buscopan compositum 20 mg/2.5 g
05 1Buscopresc Compositum
06 1DIPIRONA
07 1DIPYRONE
08 1Difebril
09 1Dipyrine
10 1Metalgold
11 1Metamizol Alter
12 1Metamizol Cinfa
13 1Metamizol Gobens
14 1Metamizol Kalceks
15 1Metamizol Normon
16 2Metamizol Spirig HC
17 1Metamizol-Mepha
18 1Metamizole Base
19 2Metamizole(Analgin)
20 4Minalgin
21 4Novalgin
22 3Novalgina
23 1Novaminsulfon Synthetic
24 1Omalgin
25 2Panalgorin
26 2Scopex Co
27 1Spasmopharm
28 1Turbet
29 1UNALGIN
30 28Blank
01 6Austria
02 1Brazil
03 2Bulgaria
04 1Canada
05 2Chile
06 3China
07 1Colombia
08 2Czech Republic
09 2Hungary
10 15India
11 3Italy
12 2Poland
13 1Russia
14 5South Africa
15 10Spain
16 12Switzerland
17 1Turkey
18 1Uzbekistan
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Novalgina
Dosage Form :
Dosage Strength : Gtt Os 20 Ml 500 Mg/Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 1000MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Novalgina
Dosage Form :
Dosage Strength : To 5 Supp 1 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Novalgina
Dosage Form :
Dosage Strength : 5 Ampoules Im Ev 1 G 2 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Cancelled
Registration Country : Spain
Metamizol Sodium; Butylscopolamine Bromide
Brand Name : Buscapina Compositum
Dosage Form : Coated Tablet
Dosage Strength : 250MG; 10 MG
Packaging :
Approval Date : 1959-06-01
Application Number : 32174
Regulatory Info : Cancelled
Registration Country : Spain
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 2500MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging : 30ml & 100ml Multi dose vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Dossier Availability- Q4 2016
Registration Country : Austria
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 500MG/ML
Packaging : 2 Ml, 5 Ml, 10 Ml
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q4 2016
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Tablet
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging : 1 x 10 T
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info : Generic
Registration Country : India
Brand Name : UNALGIN
Dosage Form : INJECTION
Dosage Strength : 500MG/ML
Packaging : 2 / 5ml amp ; 30ml vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info :
Registration Country : Czech Republic
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Czech Republic
